Four Decades for Justice
Cravath is one of the preeminent law firms for mergers and acquisitions. Our lawyers are renowned for their outstanding capabilities in complex U.S. and cross‑border deals. Over the past decade, Cravath has represented clients in more than 800 M&A transactions with an aggregate value of over $4.2 trillion, reflecting the high‑value, high‑impact transactions that we are regularly called upon to execute.
Cravath advises companies in their most critical needs across the full spectrum of corporate transactions, including mergers, acquisitions, divestitures, spin‑offs and joint ventures. In addition to—and often alongside—the mergers and acquisitions that we handle, Cravath is a leading advisor for companies and boards in high‑stakes corporate situations, including hostile takeovers and shareholder activism defense.
Both U.S. and non-U.S. clients rely on our leadership and expertise in their most transformative corporate matters, many of which involve multiple jurisdictions across diverse industries. Our lawyers navigate novel legal and business issues in the areas of consumer products, energy, fintech, healthcare, media and entertainment, pharmaceuticals, retail, technology and telecommunications.
Cravath has been consistently ranked a top‑tier firm for M&A by numerous third‑party publications and is an 11‑time recipient of the M&A Practice Group of the Year award by Law360. Our lawyers regularly earn plaudits from their clients and peers in the market:
Cravath advises companies in their most critical needs across the full spectrum of corporate transactions, including mergers, acquisitions, divestitures, spin‑offs and joint ventures. In addition to—and often alongside—the mergers and acquisitions that we handle, Cravath is a leading advisor for companies and boards in high‑stakes corporate situations, including hostile takeovers and shareholder activism defense.
Both U.S. and non-U.S. clients rely on our leadership and expertise in their most transformative corporate matters, many of which involve multiple jurisdictions across diverse industries. Our lawyers navigate novel legal and business issues in the areas of consumer products, energy, fintech, healthcare, media and entertainment, pharmaceuticals, retail, technology and telecommunications.
Cravath has been consistently ranked a top‑tier firm for M&A by numerous third‑party publications and is an 11‑time recipient of the M&A Practice Group of the Year award by Law360. Our lawyers regularly earn plaudits from their clients and peers in the market:
Deals & Cases
April 02, 2024
On April 2, 2024, Endeavor Group Holdings, Inc. (“Endeavor”), a global sports and entertainment company, announced that it has entered into a definitive agreement to be acquired by Silver Lake, the global leader in technology investing, in partnership with the Endeavor management team and additional anchor investors. Cravath is representing the independent Special Committee of Endeavor’s board of directors in connection with the transaction.
Deals & Cases
March 22, 2024
On March 21, 2024, ECN Capital Corp. (“ECN Capital”), a leading provider of business services to North American based banks, credit unions, life insurance companies, pension funds and institutional investors, announced the sale of Red Oak Inventory Finance (“Red Oak”) to BharCap Partners, a private investment firm. The transaction closed on February 21, 2024. Cravath represented ECN Capital in connection with the transaction.
Deals & Cases
February 28, 2024
On February 28, 2024, Viatris Inc. (“Viatris”), a global healthcare company, and Idorsia Ltd (“Idorsia”) announced they have entered into agreements for a significant global research and development collaboration under which Viatris will receive exclusive global development and commercialization rights to two Phase 3 assets as well as the potential to add additional innovative assets in the future.
Deals & Cases
February 12, 2024
On February 12, 2024, CymaBay Therapeutics (“CymaBay”) and Gilead Sciences, Inc. (“Gilead”) announced a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis, complements Gilead’s existing liver portfolio and aligns with its longstanding commitment to bringing transformational medicines to patients. Cravath is representing CymaBay in connection with the transaction.
Deals & Cases
February 12, 2024
On February 12, 2024, Martin Marietta Materials, Inc. (“Martin Marietta”) announced that on February 11, 2024, it entered into a definitive agreement to acquire 20 active aggregates operations in Alabama, South Carolina, South Florida, Tennessee, and Virginia from affiliates of Blue Water Industries LLC (“BWI Southeast”) for $2.05 billion in cash. Additionally, on February 9, 2024, Martin Marietta completed its previously announced divestiture of its South Texas cement and related concrete operations to CRH Americas Materials, Inc., a subsidiary of CRH plc, for $2.1 billion in cash. Cravath is representing Martin Marietta in connection with the transactions.
Activities & Publications
April 17, 2024
Cravath partner Jin‑Kyu Baek was selected to join the 2024 Leadership Council on Legal Diversity (LCLD) Fellows Program. The LCLD, which was founded in 2009 as an organization of chief legal officers and law firm managing partners committed to creating a more diverse and inclusive legal profession, selects attorneys “who have shown promising leadership potential” to participate in the Fellows Program, which is a year‑long, multi‑tiered professional development series that involves personal development opportunities, leadership training, and relationship‑building resources.
Activities & Publications
April 12, 2024
On April 11, 2024, Cravath of counsel Benjamin G. Joseloff participated in the 10th National Conference on CFIUS, which was hosted by the American Conference Institute from April 10-12, 2024 in Arlington, VA. Ben spoke on a panel entitled “Introduction to CFIUS: Your A-to-Z Guide to Filing Requirements, Timelines, Mitigation, Enforcement, Penalties and Beyond,” which reviewed the basic regulatory standard necessary for a Committee for Foreign Investment in the United States (“CFIUS”) filing, the national security reasons for CFIUS filings, the scrutiny given to filings and the processing timelines.
Activities & Publications
April 10, 2024
Cravath partner Richard Hall served as contributing editor of The Legal 500’s 2024 “Mergers & Acquisitions Country Comparative Guide,” which was published in April 2024. The guide provides a pragmatic overview of M&A laws and regulations across a variety of jurisdictions. Together with Richard, partner Daniel J. Cerqueira authored the United States chapter of the guide, which reviews M&A trends, the current state of the market and key considerations for companies and shareholders.
Activities & Publications
March 22, 2024
On March 21, 2024, Cravath partner Daniel J. Cerqueira participated in DealFlow Events’ 2024 Activist Investor Conference, which was held in New York City. Dan spoke on a panel entitled “The Impact of Shareholder Activism on Global M&A.”
Activities & Publications
March 21, 2024
Five Cravath partners were selected to serve on Law360’s 2024 Editorial Advisory Boards: Wes Earnhardt (Media & Entertainment), Evan Norris (Cybersecurity & Privacy), Helam Gebremariam (Securities), Bethany A. Pfalzgraf (Mergers & Acquisitions) and Maurio A. Fiore (Private Equity). As Editorial Advisory Board members, they will provide feedback on Law360’s coverage and expert insight on how best to shape future coverage.
Deals & Cases
April 02, 2024
On April 2, 2024, Endeavor Group Holdings, Inc. (“Endeavor”), a global sports and entertainment company, announced that it has entered into a definitive agreement to be acquired by Silver Lake, the global leader in technology investing, in partnership with the Endeavor management team and additional anchor investors. Cravath is representing the independent Special Committee of Endeavor’s board of directors in connection with the transaction.
Deals & Cases
March 22, 2024
On March 21, 2024, ECN Capital Corp. (“ECN Capital”), a leading provider of business services to North American based banks, credit unions, life insurance companies, pension funds and institutional investors, announced the sale of Red Oak Inventory Finance (“Red Oak”) to BharCap Partners, a private investment firm. The transaction closed on February 21, 2024. Cravath represented ECN Capital in connection with the transaction.
Deals & Cases
February 28, 2024
On February 28, 2024, Viatris Inc. (“Viatris”), a global healthcare company, and Idorsia Ltd (“Idorsia”) announced they have entered into agreements for a significant global research and development collaboration under which Viatris will receive exclusive global development and commercialization rights to two Phase 3 assets as well as the potential to add additional innovative assets in the future.
Deals & Cases
February 12, 2024
On February 12, 2024, CymaBay Therapeutics (“CymaBay”) and Gilead Sciences, Inc. (“Gilead”) announced a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis, complements Gilead’s existing liver portfolio and aligns with its longstanding commitment to bringing transformational medicines to patients. Cravath is representing CymaBay in connection with the transaction.
Deals & Cases
February 12, 2024
On February 12, 2024, Martin Marietta Materials, Inc. (“Martin Marietta”) announced that on February 11, 2024, it entered into a definitive agreement to acquire 20 active aggregates operations in Alabama, South Carolina, South Florida, Tennessee, and Virginia from affiliates of Blue Water Industries LLC (“BWI Southeast”) for $2.05 billion in cash. Additionally, on February 9, 2024, Martin Marietta completed its previously announced divestiture of its South Texas cement and related concrete operations to CRH Americas Materials, Inc., a subsidiary of CRH plc, for $2.1 billion in cash. Cravath is representing Martin Marietta in connection with the transactions.
Activities & Publications
April 17, 2024
Cravath partner Jin‑Kyu Baek was selected to join the 2024 Leadership Council on Legal Diversity (LCLD) Fellows Program. The LCLD, which was founded in 2009 as an organization of chief legal officers and law firm managing partners committed to creating a more diverse and inclusive legal profession, selects attorneys “who have shown promising leadership potential” to participate in the Fellows Program, which is a year‑long, multi‑tiered professional development series that involves personal development opportunities, leadership training, and relationship‑building resources.
Activities & Publications
April 12, 2024
On April 11, 2024, Cravath of counsel Benjamin G. Joseloff participated in the 10th National Conference on CFIUS, which was hosted by the American Conference Institute from April 10-12, 2024 in Arlington, VA. Ben spoke on a panel entitled “Introduction to CFIUS: Your A-to-Z Guide to Filing Requirements, Timelines, Mitigation, Enforcement, Penalties and Beyond,” which reviewed the basic regulatory standard necessary for a Committee for Foreign Investment in the United States (“CFIUS”) filing, the national security reasons for CFIUS filings, the scrutiny given to filings and the processing timelines.
Activities & Publications
April 10, 2024
Cravath partner Richard Hall served as contributing editor of The Legal 500’s 2024 “Mergers & Acquisitions Country Comparative Guide,” which was published in April 2024. The guide provides a pragmatic overview of M&A laws and regulations across a variety of jurisdictions. Together with Richard, partner Daniel J. Cerqueira authored the United States chapter of the guide, which reviews M&A trends, the current state of the market and key considerations for companies and shareholders.
Activities & Publications
March 22, 2024
On March 21, 2024, Cravath partner Daniel J. Cerqueira participated in DealFlow Events’ 2024 Activist Investor Conference, which was held in New York City. Dan spoke on a panel entitled “The Impact of Shareholder Activism on Global M&A.”
Activities & Publications
March 21, 2024
Five Cravath partners were selected to serve on Law360’s 2024 Editorial Advisory Boards: Wes Earnhardt (Media & Entertainment), Evan Norris (Cybersecurity & Privacy), Helam Gebremariam (Securities), Bethany A. Pfalzgraf (Mergers & Acquisitions) and Maurio A. Fiore (Private Equity). As Editorial Advisory Board members, they will provide feedback on Law360’s coverage and expert insight on how best to shape future coverage.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.